ARCHIVES

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

In Brief: Gregory Curt Nominated DCT Deputy DCC Seeks Occupational Cancer, Prevention Branch Chiefs

October 26, 1984

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012